Protalix BioTherapeutics, Inc. Contract Liability (Deferred Revenue)
Protalix BioTherapeutics, Inc. (PLX) had Contract Liability (Deferred Revenue) of $12.70 million as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2024-08-14
- 2024-06-30: Contract with Customer, Liability, Current $12.70M.
- 2024-03-31: Contract with Customer, Liability, Current $11.04M.
- 2023-12-31: Contract with Customer, Liability, Current $0.00.
- 2023-03-31: Contract with Customer, Liability, Current $11.79M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2024-06-30 | $12.70M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $11.04M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $0.00 10-K · filed 2024-03-14 |
| 2023-03-31 | $11.79M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $13.18M 10-K · filed 2024-03-14 |
| 2022-09-30 | $14.79M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $10.22M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $11.80M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $8.55M 10-K · filed 2023-02-27 |
| 2021-09-30 | $15.16M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $18.11M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $2.56M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $5.39M 10-K · filed 2022-03-31 |
| 2020-09-30 | $16.72M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $18.35M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $19.01M 10-Q · filed 2020-06-01 |
| 2019-12-31 | $16.34M 10-K · filed 2021-03-30 |
| 2019-09-30 | $11.61M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $7.54M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $9.43M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $9.87M 10-K · filed 2020-03-12 |
| 2018-09-30 | $9.79M 10-Q · filed 2019-03-18 |
| 2018-06-30 | $3.42M 10-Q · filed 2019-03-18 |
| 2018-03-31 | $2.65M 10-Q · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |